Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 11/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.57 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.54 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15795458 | 0.86 | CYP19A1 (0.71) | CYP19A1NPC1RAB9AHRH4HSP90AB1 | |
| Imidazole SCHEMBL28221370 | 0.85 | CYP19A1 (0.50) | CYP19A1NPC1RAB9AHRH4HSP90AB1 | |
| SCHEMBL28220729 | 0.85 | CYP19A1 (0.70) | CYP19A1NPC1RAB9AHRH4HSP90AB1 | |
| SCHEMBL12022159 | 0.84 | KCNMA1 (0.69) | CYP19A1NPC1RAB9AHRH4HSP90AB1 | |
| SCHEMBL3103838 | 0.84 | CYP19A1 (0.68) | CYP19A1NPC1RAB9AHRH4HSP90AB1 | |
| SCHEMBL15803296 | 0.83 | CYP19A1 (0.56) | CYP19A1NPC1RAB9AHSP90AB1NOTUM | |
| SCHEMBL27777026 | 0.83 | GBA1 (0.57) | CYP19A1NPC1RAB9AHRH4MAOA | |
| SCHEMBL13702605 | 0.83 | TUBB4A (0.58) | CYP19A1NPC1RAB9AHSP90AB1 | |
| SCHEMBL28221634 | 0.83 | CYP19A1 (0.60) | CYP19A1NPC1RAB9AHRH4HSP90AB1 | |
| SCHEMBL2502451 | 0.82 | CYP19A1 (0.66) | CYP19A1NPC1RAB9AHRH4HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112552490-B | Nucleic acid grafted semiconductor polymer, nucleic acid probe, and preparation method and application thereof | 南方科技大学 | 2023-04-14 | — | — | CN | claimed |
| US-20210324197-A1 | SOLID COLOR FILM, PREPARATION METHOD THEREOF, AND DISPLAY DEVICE | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2021-10-21 | — | — | US | claimed |
| CN-112552490-A | Nucleic acid grafted semiconductor polymer, nucleic acid probe, and preparation method and application thereof | 南方科技大学 | 2021-03-26 | — | — | CN | claimed |
| CN-111183144-A | Click-based connection | 贝瑟克里科有限公司 | 2020-05-19 | — | — | CN | claimed |
| CN-110294725-A | A kind of derivative and its process for catalytic synthesis of sponge furanone | 广东医科大学 | 2019-10-01 | — | — | CN | claimed |
| CN-110183378-A | A kind of derivative and its process for catalytic synthesis of niacinamide | 广东医科大学 | 2019-08-30 | — | — | CN | claimed |
| CN-105324116-B | Adjust the multivalence interaction with the biopolymer of polyproline bracket | 新加坡科技研究局 | 2019-03-29 | — | — | CN | claimed |
| CN-105324116-A | Tailoring multivalent interactions of biopolymers with a polyproline scaffol | AGENCY SCIENCE TECH & RES | 2016-02-10 | — | — | CN | claimed |
| US-20260023080-A1 | METHOD FOR PROTEOME-WIDE DISCOVERY OF COVALENT LIGANDS AND COMPOSITIONS THEREOF | BRIDGENE BIOSCIENCES INC (US) | 2026-01-22 | — | — | US | disclosed |
| US-20250367371-A1 | HYBRID BIOELECTRONIC/ENGINEERED CELL IMPLANTABLE SYSTEM FOR THERAPEUTIC AGENTS DELIVERY AND APPLICATIONS THEREOF | UNIV NORTHWESTERN (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250313544-A1 | INHIBITORS OF GLUTATHIONE S-TRANSFERASE ZETA 1 (GSTZ1) AND METHODS OF USE | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2025-10-09 | — | — | US | disclosed |
| US-12371461-B2 | Nemo coiled coil mimics and methods of using same | NEW YORK UNIVERSITY (US) | 2025-07-29 | — | — | US | disclosed |
| WO-2025137293-A2 | ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS | Roche Sequencing Solutions, Inc. (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025091023-A1 | ENGINEERED CELL TRANSFECTED BY ALL-IN-ONE VECTOR FOR THERAPEUTIC AGENTS PRODUCTION AND DELIVERY AND APPLICATIONS THEREOF | NORTHWESTERN UNIVERSITY (US) | 2025-05-01 | — | — | WO | disclosed |
| US-20100254943-A1 | AMINO ACID SUBSTITUTED MOLECULES | ALLOZYNE, INC. (US) | 2010-10-07 | — | — | US | disclosed |
| US-20080200641-A1 | AMINO ACID SUBSTITUTED MOLECULES | ALLOZYNE, INC. (US) | 2008-08-21 | — | — | US | disclosed |
| CN-101223272-A | Expanding the eukaryotic genetic code | SCRIPPS RESEARCH INST (US) | 2008-07-16 | — | — | CN | disclosed |
| US-20080096819-A1 | Amino acid substituted molecules | ALLOZYNE, INC. (US) | 2008-04-24 | — | — | US | disclosed |
| CN-101160525-A | Genetic code increase of non-natural active amino acid | SCRIPPS RESEARCH INST (US) | 2008-04-09 | — | — | CN | disclosed |
| CN-101151366-A | Proteins incorporating alkynyl amino acids into eubacteria in vivo | SCRIPPS RESEARCH INST (US) | 2008-03-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12371461-B2 | Nemo coiled coil mimics and methods of using same | COIL, CALCOCO2, NCAPH | CYP19A1 3378/4885NPC1 503/4885RAB9A 4061/4885 |
| US-20210324197-A1 | SOLID COLOR FILM, PREPARATION METHOD THEREOF, AND DISPLAY DEVICE | ADAR, ADA, ACHE | CYP19A1 1137/4885NPC1 3931/4885RAB9A 757/4885 |
| US-20080096819-A1 | Amino acid substituted molecules | BCAT2, DNPEP, PTMS | CYP19A1 3595/4885NPC1 3938/4885RAB9A 3608/4885 |
| US-20100254943-A1 | AMINO ACID SUBSTITUTED MOLECULES | BCAT2, DNPEP, PTMS | CYP19A1 3595/4885NPC1 3938/4885RAB9A 3608/4885 |
| US-20080200641-A1 | AMINO ACID SUBSTITUTED MOLECULES | BCAT2, DNPEP, PTMS | CYP19A1 3595/4885NPC1 3938/4885RAB9A 3608/4885 |
| US-20260023080-A1 | METHOD FOR PROTEOME-WIDE DISCOVERY OF COVALENT LIGANDS AND COMPOSITIONS THEREOF | SRMS, PTMS, CHAMP1 | CYP19A1 4024/4885NPC1 3261/4885RAB9A 2452/4885 |
| US-20250313544-A1 | INHIBITORS OF GLUTATHIONE S-TRANSFERASE ZETA 1 (GSTZ1) AND METHODS OF USE | GSTK1, GSTM1, GSTM2 | CYP19A1 1632/4885NPC1 1795/4885RAB9A 2570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.